SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending downwards as investors react to increased spending forecasts related to AI, drawing comparisons to the company's metaverse investments; the community is debating whether this dip represents a buying opportunity or signals deeper concerns about Meta's direction, with some citing a one-time tax charge as the primary driver, while others point to overall market weakness or algorithmic reactions.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the iconic Rage Guy meme, emphasizing a return to OG meme culture and community-driven growth. Discussions highlight the importance of belief and shared effort, with community members expressing bullish sentiment and encouraging each other to "RAGE ON" and "work for their bags". The movement is positioned as a cultural correction against soulless memecoins.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors anticipate the company's earnings report and how effectively it's monetizing data through AI partnerships. Community members are discussing revenue estimates, daily active user growth, and the potential for a post-earnings rally or selloff. Some are also pointing to potential connections with other trending stocks and broader market factors.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific (CORZ) is trending as shareholders prepare to vote on a proposed merger with CoreWeave ($CRWV); discussions center on whether the deal undervalues CORZ, especially given the potential for AI infrastructure growth. Some shareholders believe CORZ is worth more as a standalone company, citing peers and potential for new contracts, while others worry about financial stability without the merger. The vote outcome is uncertain, leading to speculation about future directions and potential board changes.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is trending downwards as the community discusses concerns around declining traffic, margin pressures, and lowered sales outlook, potentially driven by consumer spending habits and pricing. Some traders believe the stock is oversold, presenting a buying opportunity, while others express concerns about the company's current leadership and competitive landscape. Community members are also debating if a change in strategy is needed to better appeal to a broader customer base.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid unconfirmed rumors of a potential buyout, sparking active discussions within the investment community. The speculation surfaces as the company focuses on oncology and prepares to report earnings in November. Community members are weighing the potential deal price and strategic implications for Moderna's future.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent BioSolutions is trending due to renewed optimism fueled by raised FY25 EBITDA guidance and a potential short squeeze, with the community actively discussing target prices and the possibility of further upside. A top-line Q3 beat and recent earnings surprise are adding to the positive sentiment. Some traders are closely monitoring the stock's short interest and anticipating a significant price movement.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC is trending as investors digest recent earnings and a reduced dividend, leading to a sharp price decline. The community is debating whether this presents a value opportunity or signals deeper challenges for the company, with some citing an overreaction and oversold conditions. Bullish sentiment is building around potential for a price rebound given its inclusion in the S&P 500.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is seeing active discussion around its correlation to Bitcoin and upcoming earnings, with community members debating its valuation relative to its Bitcoin holdings and expressing concerns about potential downside. Some traders are closely watching options activity and speculating on potential catalysts, while others question the company's strategy and management. The stock's performance relative to Bitcoin's price movement remains a key talking point.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as community members discuss the potential for a short squeeze, driven by high short interest and optimism around the company's pipeline. Chatter revolves around buyout speculation, comparisons to competitors, and anticipation for upcoming presentations at ObesityWeek. The stock's recent performance and market dynamics in the obesity treatment sector are also fueling the conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>While the consensus EPS estimate suggests a decline from a year ago, revenue is expected to rise by more than 12% year over year.</li><li>A retail user expected a “well-thought-out earnings call with a road to a bright future, no matter what the numbers say.”</li><li>Stung by the headwinds, UnitedHealth stock is down more than 23% this year.</li></ul>Healthcare services giant UnitedHealth, Inc. (UNH), which has been facing company-specific, macro, and geopolitical challenges, is scheduled to announce its quarterly results before the market opens on Tuesday.Stung by the headwinds,&nbsp;<a href="https://stocktwits.com/symbol/UNH">UnitedHealth stock</a> is down more than 23% this year.<h2 class="st-heading-2">What Street Expects For UNH’s Q3</h2>According to the Fiscal.ai-compiled consensus estimates, UnitedHealth is expected to report adjusted earnings per share (EPS) of $2.81 and revenue of $113.06 billion. While the consensus EPS estimate suggests a decline from the year-ago’s $3.57, revenue is expected to rise over 12% year-over-year (YoY).In a mid-September note, Morgan Stanley analyst Erin Wright said he came away from an investor dinner with the UNH management team incrementally positive. He noted that the management team, led by CEO Stephen Hemsley, oozed conviction in a turnaround, driven by Medicare Advantage (MA) and Optum Health improvement.Among the headwinds the company faces are higher medical loss ratios that have pressured margins, pricing,&nbsp;as well as operational mistakes in its MA and Affordable Care Act (ACA) businesses.&nbsp;It also faces criminal investigations into the MA billing practices, and the business practices of its&nbsp;Optimum unit, as well as other lawsuits for allegedly improperly denying claims.The company withdrew its full-year 2025 guidance in mid-May, replaced Andrew Witty as CEO with former CEO Hemsley, citing unexpected medical costs and challenges with its Medicare strategy. It, however, reinstated the annual guidance when it released its second-quarter results in late July. The current outlook calls for revenue of $445.5 billion to $448 billion and adjusted EPS of at least $16.<h2 class="st-heading-2">How Retail Is Positioned For Q3 Results</h2>Retail sentiment toward UnitedHealth stock flipped to ‘bullish’ by early Tuesday from ‘bearish’ a day ago. The message volume on the stream has picked up pace to ‘high’ levels.<figure class="image"><img style="aspect-ratio:623/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_28_at_1_35_06_AM_png_d1fda1994a.webp" alt="Screenshot 2025-10-28 at 1.35.06 AM.png" width="623" height="53"><figcaption>UNH sentiment and message volume as of 1:30 a.m ET, Oct. 28 | source: Stocktwits</figcaption></figure>A bullish user looked ahead to better performance after a “kitchen-sink” second quarter.<stembedurl>https://stocktwits.com/newtwo99/message/633929931</stembedurl>Another user expected a “well-thought-out earnings call with a road to a bright future no matter what the numbers say.” If the numbers come in better than expected, they see it as an added advantage.<stembedurl>https://stocktwits.com/PhoenixRisingMD/message/633928829</stembedurl><h2 class="st-heading-2">Wall Street Lift Price Targets Ahead Of Q3 Print</h2>Since the start of October, UnitedHealth’s stock has received a string of price target hikes, with the updated price targets ranging from $335 to $433, according to the Fly. While lifting its price target to $409 from $317 earlier this month, Jefferies analyst David Windley said he sees upside for MA margins in 2026, thanks to assertive group repricing efforts. The analyst has a ‘Buy’ rating on the stock.Goldman Sachs initiated coverage of the UnitedHealth stock with a ‘Buy rating’ and $406 price target. While the firm believes that the managed care industry faces its most significant underwriting downturn in over 15 years, it recommended increased exposure to MA, factoring in a margin recovery phase beginning in 2026.&nbsp;After bumping up the price target to $430 from $300, Mizuho, which has an ‘Overweight’ rating, noted increased earnings visibility on key issues and rotation into the healthcare sector.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-nxp-semiconductor-stock-rose-in-today-s-after-hours/cLGjTBXR3ur">Why NXP Semiconductor Stock Rose In Today’s After-hours</a>

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

UnitedHealth Stock In Spotlight Ahead Of Earnings: Retail Traders Bet On Recovery After ‘Kitchen-Sink’ Q2

While the consensus EPS estimate suggests a decline from a year ago, revenue is expected to rise by more than 12% year over year.

UnitedHealth (UNH) Stock In Spotlight Ahead Of Earnings: Retail Traders Bet On Recovery After ‘Kitchen-Sink’ Q2

Equity

A $38 Trillion Problem: ETFs to Play Rising Debt Pressure

With U.S. debt hitting a record $38 trillion amid a prolonged shutdown, investors should turn to defensive ETF strategies for stability.

Feeling Tech-Heavy? Diversify With These ETFs Amid AI Bubble Concerns

Wall Street warns of an AI equity bubble as mega-cap tech surges, prompting investors to diversify into ETFs for balanced growth.

The Zacks Analyst Blog Highlights VTV, JAVA, AVLV, IWS and VBR

Amid market volatility, value ETFs like VTV, JAVA, AVLV, IWS, and VBR offer stability, undervalued stock exposure, and potential long-term gains for investors.

Why Value ETFs Investing Could Be a Smart Move Right Now

Amid market uncertainty and overvalued equities, value investing with ETFs offer a safer, long-term path to steady returns.

Should Vanguard Value ETF (VTV) Be on Your Investing Radar?

Markets Up but Defensive ETFs Are Still a Wise Choice

Market volatility and outflows push investors toward defensive ETFs, with staples, value and quality funds offering protection and stability.

ETFs to Consider as Goldman Sachs Flags AI Risks

Goldman Sachs warns of rising AI bubble risks, making diversification with equal-weight, value and quality ETFs a smart defensive move.

September Effect and ETFs: What Lies Ahead for Investors?

As the September effect looms over Wall Street, investors should eye defensive ETFs like consumer staples, gold and dividends to cushion volatility.

Diversify With ETFs and Stay Ahead in Volatile Markets

Amid AI bubble worries and tech sell-offs, investors turn to value, consumer staples, gold and international ETFs for diversification.

Vanguard Group, Inc. - Vanguard Value ETF

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

VTV
Vanguard Value ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VTV News

VTVVanguard Value ETF